Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China
Ningying Mao,1 Beth Lesher,2 Qifa Liu,3 Lei Qin,2 Yixi Chen,4 Xin Gao,2 Stephanie R Earnshaw,5 Cheryl L McDade,5 Claudie Charbonneau,61School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, People's Republic of China; 2Pharmerit International, Bethesda, MD...
Saved in:
Main Authors: | Mao NY (Author), Lesher B (Author), Liu QF (Author), Qin L (Author), Chen YX (Author), Gao X (Author), Earnshaw SR (Author), McDade CL (Author), Charbonneau C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fungal Infections in Immunocompromised Hosts
by: Kontoyiannis, Dimitrios P.
Published: (2019) -
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China
by: Lesher B, et al.
Published: (2016) -
Culture-Negative Endocarditis in an Immunocompromised Patient: A Case of Suspected and Co-Infection
by: Steven Swarath MBBS, et al.
Published: (2023) -
Position and enforcement practice of the People's Republic of China's pharmaceutical data exclusivity protection
by: Li N, et al.
Published: (2016) -
Mobile air-decontamination units: Can they be used for immunocompromised patients at high risk for fungal infections?
by: Joris Voisin, et al.
Published: (2024)